FDA shakes up drug marketing units to achieve multiple goals

03/11/2013 | PharmExec.com

The FDA's Office of Prescription Drug Promotion is restructuring its professional and consumer marketing review divisions to provide tight supervision of direct-to-consumer advertising. The changes, which include organizing oversight by therapeutic class instead of target audience, will help achieve the goals of removing redundancy, enhancing work distribution and increasing efficiency, according to Center for Drug Evaluation and Research Director Dr. Janet Woodcock.

View Full Article in:

PharmExec.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI